Table 3.

Guidance for telemedicine visits for rheumatology clinicians

New patient visits	Follow-up patient visits
Favourable for telemedicine:	Favourable for telemedicine:
Laboratory abnormalities, including positive autoantibodies without symptoms	Flare of certain rheumatic and musculoskeletal diseases, such as OA, FM, inflammatory arthritis and crystalline-induced arthritis
Second opinion managing an existing rheumatic condition
Musculoskeletal complaints
Less favourable for telemedicine:	Less favourable for telemedicine:
New symptoms of CTDs and vasculitis	Flare of myositis or vasculitis